3Degrees Welcomes David Dines to Board of Directors
11.12.2025 17:00:00 CET | Business Wire | Press Release
3Degrees, a global leader in renewable energy and climate solutions, is pleased to announce the appointment of David Dines to its Board of Directors, effective December 8, 2025.
Dines brings more than four decades of leadership experience across global energy, commodities, financial services, transportation, and industrial markets. He served on the executive team as Chief Financial Officer and Corporate Senior Vice President at Cargill, Inc., the largest privately held company in the United States, where he oversaw enterprise-wide financial strategy, capital deployment, and financial performance. During his 29-year career at Cargill, Dines led multiple global businesses, played key roles in major technology and process transformations, and was a member of Cargill’s Commodity Risk, Financial Risk, and Process, Data, and Technology Committees.
“We are thrilled to welcome David to the 3Degrees board,” said Philippe Vedrenne, CEO, 3Degrees. “He has an exceptional command of financial stewardship, global risk management, and large-scale operational transformation. David’s experience leading complex commodity and financial businesses, combined with his deep commitment to mission-driven organizations, will be a crucial asset as we accelerate 3Degrees’ next decade of growth.”
In addition to his corporate leadership roles, Dines serves on several boards, including Willamette Egg Farms and the J.F. Brennan Company, is a board observer of MyLand, and an advisor to Proterra Investment Partners. He has held board leadership roles in multiple nonprofit organizations, currently serving on the board of the Guthrie Theater and as a trustee for the Center for Creative Leadership.
At 3Degrees, Dines will serve as chair of the Risk Management Committee of the board and a member of its Human Capital Committee.
“I am honored to join the board of 3Degrees at a moment when climate leadership and innovative market solutions are more essential than ever,” said Dines. “I admire 3Degrees’ role helping organizations navigate decarbonization with integrity, creativity, and impact and look forward to working with the board and management team to support the company’s continued leadership and expansion.”
About 3Degrees
3Degrees is a leading global climate solutions provider, pioneer of environmental markets, and Certified B Corporation. Our work is driven by the need for urgent climate action, and has been for 20 years. We deliver a full suite of clean energy and decarbonization solutions to help global Fortune 500 companies and other organizations achieve their climate goals and address emissions in the fight against climate change. The 3Degrees team brings a commitment to integrity and deep expertise in climate strategy and implementation across scopes 1, 2, and 3 emissions, including global environmental commodities, renewable energy and carbon project development, supply chain decarbonization, and clean fuel standards. We help develop and deploy impactful climate solutions that make good business sense and advance an equitable transition to the low-carbon future. Learn more at 3Degrees.com or follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251211086162/en/
Contacts
Rachel Fagan, rfagan@3degrees.com, 512.791.2083
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis3.3.2026 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, and the condition can be accompanied by nail involvement and joint pain. Because lesions on the palms are visible to others and lesions on the soles can cause pain while walking, daily functioning can be significantly restricted, leading in a substantial reduction in quality of life. PPP has a pathophysiology distinct from psoriasis and pustular psoriasis, and treatment can be challenging, unde
Yubico Establishes Singapore as Third Global Headquarters Accelerating Asia Pacific Growth3.3.2026 01:00:00 CET | Press Release
Yubico (NASDAQ STOCKHOLM: YUBICO), a cybersecurity company, inventor of FIDO passkeys and creator of the YubiKey, the most secure passkey, today announced the opening of its third global headquarters in Singapore. This announcement reinforces Yubico’s long-term commitment to the Asia Pacific region and builds on its role in advancing open authentication standards, while shaping a safer digital world for all. The new office complements Yubico’s existing global headquarters in Stockholm, Sweden and Santa Clara, USA, reflecting its strategy to serve a growing international user base by helping customers deploy YubiKeys at scale to adapt to a rapidly evolving cybersecurity landscape. “As the digital economy grows, there’s a decisive shift across Asia Pacific, where organizations are moving beyond legacy multi-factor authentication to meet rigorous new national regulations for identity protection,” said Jerrod Chong, Acting Chief Executive Officer at Yubico, a Singaporean. “The expansion of
IFF Completed the Divestiture of Soy Crush, Concentrates and Lecithin Businesses2.3.2026 22:15:00 CET | Press Release
IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its soy crush, concentrates and lecithin businesses to Bunge. This transaction does not include IFF’s soy isolates business. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2026 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20260302231096/en/
Verimatrix ReAccess Earns Gold 2026 Merit Award for Telecom & Wireless2.3.2026 17:50:00 CET | Press Release
Regulatory News: Verimatrix (Euronext Paris: VMX), a leading provider of security solutions for a safer connected world, today announced that its Verimatrix ReAccess solution was honored with a gold 2026 Merit Award for Telecom & Wireless. The industry accolade recognizes the company’s next-generation content security solution that modernizes legacy Conditional Access Systems (CAS) across DVB, IPTV and OTT networks without requiring costly hardware replacements or field service interventions. Judged by industry executives, media professionals and technology consultants, the Merit Awards evaluate submissions from across the telecommunications landscape. Verimatrix ReAccess enables secure, over-the-air (OTA) software updates to deployed set-top boxes (STBs), delivering operator cost savings, reduced operational complexity, and ongoing protection against piracy. It also empowers operators to continuously strengthen content security, eliminating the need for costly hardware replacements. U
Textron Aviation Launches Donation Campaign to Support 2026 Special Olympics Airlift; Continues Nationwide Call for Volunteer Doves2.3.2026 17:00:00 CET | Press Release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the launch of a donation campaign benefitting Special Olympics in support of the 2026 Special Olympics Airlift, a nationwide effort that brings athletes and coaches to the Special Olympics USA Games through the generosity of volunteer pilots, aircraft owners and operators known as Doves. Financial contributions go directly to the Special Olympics, a 501(c)(3) charitable organization. New for the 2026 event, the donation campaign serves a vital role in ensuring each delegation has what it needs for a smooth and welcoming travel experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302196418/en/ Textron Aviation launches donation campaign to support 2026 Special Olympics Airlift; continues nationwide call for volunteer Doves (Photo credit: Textron Aviation). “This campaign reflects the spirit of unity and generosity that defines the Special Olym
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom